A comparative efficacy and safety analysis of subcutaneous infliximab and vedolizumab in patients with Crohn's Disease and Ulcerative Colitis
Peyrin-Biroulet L, Arkkila P, Armuzzi A, Atreya R, Danese S, Ferrante M, Guardiola J, Jahnsen J, Louis E, Lukas M, Reinisch W, Roblin X, Smith PJ, Kwon TS, Kim JY, Yoon SW, Kim DH (2022)
Publication Type: Conference contribution
Publication year: 2022
Journal
Publisher: OXFORD UNIV PRESS
City/Town: OXFORD
Pages Range: I1116-I117
Conference Proceedings Title: JOURNAL OF CROHNS & COLITIS
DOI: 10.1093/ecco-jcc/jjab232.112
Authors with CRIS profile
Raja Atreya
Professur für Translationale Immunforschung bei chronisch entzündlichen Darmerkrankungen (Heisenberg-Professur)
Involved external institutions
Centre Hospitalier Universitaire de Nancy / CHU Hôpitaux de Brabois
France (FR)
Helsingin yliopisto / University of Helsinki
Finland (FI)
Catholic University of the Sacred Heart / Università Cattolica del Sacro Cuore
Italy (IT)
Università Vita-Salute San Raffaele (UniSR)
Italy (IT)
Katholieke Universiteit Leuven (KUL) / Catholic University of Leuven
Belgium (BE)
Bellvitge University Hospital / Hospital Universitari de Bellvitge
Spain (ES)
University of Oslo
Norway (NO)
Centre Hospitalier Universitaire de Liège (CHU Liège)
Belgium (BE)
Klinické Centrum ISCARE
Czech Republic (CZ)
Medizinische Universität Wien
Austria (AT)
Centre Hospitalier Universitaire de Saint-Étienne (CHU)
France (FR)
Royal Liverpool and Broadgreen University Hospitals NHS Trust
United Kingdom (GB)
France (FR)
Helsingin yliopisto / University of Helsinki
Finland (FI)
Catholic University of the Sacred Heart / Università Cattolica del Sacro Cuore
Italy (IT)
Università Vita-Salute San Raffaele (UniSR)
Italy (IT)
Katholieke Universiteit Leuven (KUL) / Catholic University of Leuven
Belgium (BE)
Bellvitge University Hospital / Hospital Universitari de Bellvitge
Spain (ES)
University of Oslo
Norway (NO)
Centre Hospitalier Universitaire de Liège (CHU Liège)
Belgium (BE)
Klinické Centrum ISCARE
Czech Republic (CZ)
Medizinische Universität Wien
Austria (AT)
Centre Hospitalier Universitaire de Saint-Étienne (CHU)
France (FR)
Royal Liverpool and Broadgreen University Hospitals NHS Trust
United Kingdom (GB)
How to cite
APA:
Peyrin-Biroulet, L., Arkkila, P., Armuzzi, A., Atreya, R., Danese, S., Ferrante, M.,... Kim, D.H. (2022). A comparative efficacy and safety analysis of subcutaneous infliximab and vedolizumab in patients with Crohn's Disease and Ulcerative Colitis. In JOURNAL OF CROHNS & COLITIS (pp. I1116-I117). OXFORD: OXFORD UNIV PRESS.
MLA:
Peyrin-Biroulet, L., et al. "A comparative efficacy and safety analysis of subcutaneous infliximab and vedolizumab in patients with Crohn's Disease and Ulcerative Colitis." Proceedings of the JOURNAL OF CROHNS & COLITIS OXFORD: OXFORD UNIV PRESS, 2022. I1116-I117.
BibTeX: Download